Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Adhera Therapeutics
Adhera Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Prestalia
Perindopril arginine
,
Amlodipine besylate
2015-01-21
—
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Benzocaine
healthy volunteers/patients
,
long qt syndrome
,
knee osteoarthritis
,
osteoarthritis
,
stomach neoplasms
,
lung neoplasms
,
chronic obstructive pulmonary disease
,
atrial fibrillation
,
obstructive lung diseases
,
exocrine pancreatic insufficiency
,
left ventricular function
,
atrial flutter
,
non-hodgkin lymphoma
,
multiple myeloma
,
atopic dermatitis
,
eczema
,
dermatitis
,
clear cell adenocarcinoma
,
adenomyoepithelioma
,
neoplasms
,
non-small-cell lung carcinoma
,
anemia
,
carcinoma
,
chronic renal insufficiency
,
kidney diseases
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
,
renal cell carcinoma
,
hypertriglyceridemia
,
chronic kidney failure
,
asthma
,
neoplasm metastasis
,
acidosis
,
urologic neoplasms
,
kidney neoplasms
,
neoplasms by site
,
hallucinations
,
schizophrenia
,
psychotic disorders
,
delusions
,
hyperkalemia
,
type 2 diabetes mellitus
,
diabetes mellitus
,
heart failure
,
mania
,
bipolar disorder
,
coronary artery disease
Aglatimagene besadenovec
breast neoplasms
,
ovarian neoplasms
,
renal cell carcinoma
,
colorectal neoplasms
,
pancreatic neoplasms
,
melanoma
,
liver neoplasms
,
squamous cell neoplasms
,
mesothelioma
,
follicular lymphoma
,
small cell lung carcinoma
,
triple negative breast neoplasms
,
neoplasms
,
adenocarcinoma
,
squamous cell carcinoma of head and neck
,
prostatectomy
,
castration-resistant prostatic neoplasms
,
recurrence
,
prostatic neoplasms
,
prostatic hyperplasia
,
urinary bladder neck obstruction
,
disease progression
,
neoplasm metastasis
,
erectile dysfunction
,
hypertension
,
diabetes mellitus
,
motor activity
,
coronary artery disease
,
hypersensitivity
Intermedine
proliferative vitreoretinopathy
,
neuritis
,
duchenne muscular dystrophy
,
muscular dystrophies
,
dermatomyositis
,
polymyositis
,
respiratory distress syndrome
,
glomerulonephritis
,
chronic progressive multiple sclerosis
,
amyotrophic lateral sclerosis
,
kidney diseases
,
syndrome
,
nephrosis
,
recurrence
,
iga glomerulonephritis
,
fatigue
,
relapsing-remitting multiple sclerosis
,
multiple sclerosis
,
rheumatoid arthritis
,
proteinuria
,
nephrotic syndrome
,
sarcoidosis
,
intermediate uveitis
,
posterior uveitis
,
uveitis
,
sclerosis
,
diabetic nephropathies
,
optic neuritis
,
systemic lupus erythematosus
,
panuveitis
,
scleritis
,
anterior uveitis
,
membranous glomerulonephritis
,
psoriatic arthritis
,
keratitis
,
focal segmental glomerulosclerosis
,
pulmonary sarcoidosis
,
keratoconjunctivitis sicca
,
dry eye syndromes
,
eye diseases
,
macular edema
,
demyelinating diseases
,
kidney transplantation
,
arthritis
Isoxaflutole
healthy volunteers/patients
,
cardiovascular diseases
,
asthma
,
alzheimer disease
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
,
pain
,
rheumatoid arthritis
,
arthritis
,
neoplasms
,
neoplasm metastasis
,
triple negative breast neoplasms
,
parkinson disease
,
psychotic disorders
,
mental disorders
,
heart failure
,
breast neoplasms
,
non-small-cell lung carcinoma
,
prostatic neoplasms
,
pancreatic neoplasms
,
sarcoma
,
ovarian neoplasms
,
endometrioid carcinoma
,
mucinous cystadenocarcinoma
,
fallopian tube neoplasms
,
acinar cell carcinoma
,
type 2 diabetes mellitus
,
diabetes mellitus
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use